| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.004 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.005 |